Krsnaa Diagnostics Ltd.
BSE: 543328 | Sector: Health care |
NSE: KRSNAA | ISIN Code: INE08LI01020 |
BSE 00:00 | 17 Aug | 458.15 |
-7.15 (-1.54%) |
OPEN
467.05 |
HIGH
468.20 |
LOW
457.30 |
NSE 00:00 | 17 Aug | 458.00 |
-6.90 (-1.48%) |
OPEN
466.00 |
HIGH
468.85 |
LOW
457.00 |
OPEN | 467.05 |
PREVIOUS CLOSE | 465.30 |
VOLUME | 13438 |
52-Week high | 1022.50 |
52-Week low | 457.30 |
P/E | 21.83 |
Mkt Cap.(Rs cr) | 1,439 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Krsnaa Diagnostics Ltd. (KRSNAA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 920.45 | 6.00 | 0.66 | 15585.98 |
Dr Reddy's Labs | 4319.60 | 22.70 | 0.53 | 14405.20 |
Cipla | 1025.50 | -8.35 | -0.81 | 13091.79 |
Lupin | 687.55 | 3.45 | 0.50 | 11771.67 |
Aurobindo Pharma | 580.40 | -3.45 | -0.59 | 11287.14 |
Divi's Lab. | 3749.45 | 15.25 | 0.41 | 8879.82 |
Alkem Lab | 2939.95 | -6.40 | -0.22 | 8829.81 |
Zydus Lifesci. | 399.75 | 1.25 | 0.31 | 7981.90 |
Glenmark Pharma. | 403.35 | 14.00 | 3.60 | 7567.93 |
Torrent Pharma. | 1557.20 | -15.70 | -1.00 | 6742.32 |
Apollo Hospitals | 4300.85 | -49.90 | -1.15 | 6098.30 |
Ipca Labs. | 920.35 | -5.45 | -0.59 | 5399.36 |
Alembic Pharma | 656.65 | -1.35 | -0.21 | 5051.44 |
Abbott India | 19200.15 | 76.20 | 0.40 | 4919.27 |
Laurus Labs | 591.45 | 14.05 | 2.43 | 4707.04 |
Gland Pharma | 2369.75 | 30.30 | 1.30 | 4400.71 |
Granules India | 326.95 | 10.80 | 3.42 | 3238.44 |
Glaxosmi. Pharma | 1462.25 | 12.90 | 0.89 | 3217.51 |
Ajanta Pharma | 1273.95 | -3.50 | -0.27 | 3140.64 |
Sanofi India | 6408.40 | 41.25 | 0.65 | 2956.60 |
Quick Links for Krsnaa Diagnostics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices